BioNTech SE (BNTX) Asset Utilization Ratio (2019 - 2025)
BioNTech SE (BNTX) posted Asset Utilization Ratio of 0.13 for Q4 2025, down 99.91% sequentially from 142.74 in Q3 2025, and down 99.91% YoY from 144.96 in Q4 2024.
BioNTech SE (BNTX) Asset Utilization Ratio (2019 - 2025) Analysis & Trends
BioNTech SE has reported Asset Utilization Ratio for 7 years, with the latest figure at 0.13 in Q4 2025.
- Quarterly Asset Utilization Ratio fell 99.91% year-over-year to 0.13 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.13 (down 99.91% YoY) and the FY2025 annual result came in at 0.13, up 10.09% from the prior year.
- Asset Utilization Ratio fell to 0.13 in Q4 2025 per BNTX's latest filing, from 142.74 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 105105.54 in Q1 2021 and troughed at 0.12 in Q1 2024.
- A 5-year average of 9326.08 and a median of 0.98 in 2022 frame the typical range for Asset Utilization Ratio.
- The widest YoY moves for Asset Utilization Ratio: up 97192769.24% in 2021, down 100.0% in 2021.
- Over 5 years, Asset Utilization Ratio stood at 1.28 in 2021, then plunged by 38.34% to 0.79 in 2022, then tumbled by 78.7% to 0.17 in 2023, then soared by 85991.8% to 144.96 in 2024, then plunged by 99.91% to 0.13 in 2025.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.13, 142.74, and 150.86 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn | 0.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.13 |
| Sep 30, 2025 | 0.14 |
| Jun 30, 2025 | 0.13 |
| Mar 31, 2025 | 0.13 |
| Dec 31, 2024 | 0.12 |
| Sep 30, 2024 | 0.14 |
| Jun 30, 2024 | 0.12 |
| Mar 31, 2024 | 0.12 |
| Dec 31, 2023 | 0.17 |
| Sep 30, 2023 | 0.28 |
| Jun 30, 2023 | 0.39 |
| Mar 31, 2023 | 0.53 |
| Dec 31, 2022 | 0.79 |
| Sep 30, 2022 | 0.90 |
| Jun 30, 2022 | 1.06 |
| Mar 31, 2022 | 1.32 |
| Dec 31, 2021 | 1.28 |
| Sep 30, 2021 | 29,626.18 |
| Jun 30, 2021 | 51,191.88 |
| Mar 31, 2021 | 105,105.54 |